» Articles » PMID: 22408567

Cancer and Radiation Therapy: Current Advances and Future Directions

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2012 Mar 13
PMID 22408567
Citations 844
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years remarkable progress has been made towards the understanding of proposed hallmarks of cancer development and treatment. However with its increasing incidence, the clinical management of cancer continues to be a challenge for the 21st century. Treatment modalities comprise of radiation therapy, surgery, chemotherapy, immunotherapy and hormonal therapy. Radiation therapy remains an important component of cancer treatment with approximately 50% of all cancer patients receiving radiation therapy during their course of illness; it contributes towards 40% of curative treatment for cancer. The main goal of radiation therapy is to deprive cancer cells of their multiplication (cell division) potential. Celebrating a century of advances since Marie Curie won her second Nobel Prize for her research into radium, 2011 has been designated the Year of Radiation therapy in the UK. Over the last 100 years, ongoing advances in the techniques of radiation treatment and progress made in understanding the biology of cancer cell responses to radiation will endeavor to increase the survival and reduce treatment side effects for cancer patients. In this review, principles, application and advances in radiation therapy with their biological end points are discussed.

Citing Articles

STAT1 increases the sensitivity of lung adenocarcinoma to carbon ion irradiation via HO-1-mediated ferroptosis.

Chen Y, Wang D, Luo H, Tan M, Wang Q, Wu X Mol Cell Biochem. 2025; .

PMID: 40087208 DOI: 10.1007/s11010-025-05240-z.


The Impact of Radiation Therapy on Intrathecal Drug Delivery System Functioning and Safety.

Hao D, Lee D, Shah S, Shekoohi S, Kaye A Curr Pain Headache Rep. 2025; 29(1):60.

PMID: 40085376 DOI: 10.1007/s11916-025-01375-2.


Real-time tracking of the Bragg peak during proton therapy via 3D protoacoustic Imaging in a clinical scenario.

Wang S, Gonzalez G, Sun L, Xu Y, Pandey P, Chen Y Npj Imaging. 2025; 2(1):34.

PMID: 40078731 PMC: 11893450. DOI: 10.1038/s44303-024-00039-x.


Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair.

Chiang J, Shang Z, Rosales T, Cai L, Chen W, Cai F Sci Adv. 2025; 11(11):eadt1241.

PMID: 40073141 PMC: 11900879. DOI: 10.1126/sciadv.adt1241.


Atomically-precise Au(Lys-Cys-Lys) nanoclusters for radiation sensitization.

Zeinizade E, Yousefalizideh G, Aminfar P, Horn M, Ding L, Pires L J Nanobiotechnology. 2025; 23(1):185.

PMID: 40050865 PMC: 11887354. DOI: 10.1186/s12951-025-03256-7.


References
1.
Wang-Chesebro A, Xia P, Coleman J, Akazawa C, Roach 3rd M . Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006; 66(3):654-62. DOI: 10.1016/j.ijrobp.2006.05.037. View

2.
Pollack L, Rowland J, Crammer C, Stefanek M . Introduction: charting the landscape of cancer survivors' health-related outcomes and care. Cancer. 2009; 115(18 Suppl):4265-9. DOI: 10.1002/cncr.24579. View

3.
Gill S, Thomas J, Fox C, Kron T, Rolfo A, Leahy M . Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy. Radiat Oncol. 2011; 6:145. PMC: 3217047. DOI: 10.1186/1748-717X-6-145. View

4.
Jonathan E, Bernhard E, McKenna W . How does radiation kill cells?. Curr Opin Chem Biol. 1999; 3(1):77-83. DOI: 10.1016/s1367-5931(99)80014-3. View

5.
Begg A, Stewart F, Vens C . Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011; 11(4):239-53. DOI: 10.1038/nrc3007. View